SciELO - Scientific Electronic Library Online

 
vol.21 número1Variables pre-analíticas en los análisis de gasometría sanguínea en una institución hospitalaria de tercer nivel, Cali-ColombiaMultirresistencia bacteriana: Reto terapéutico en trasplante renal índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Revista

Articulo

Indicadores

Links relacionados

  • En proceso de indezaciónCitado por Google
  • No hay articulos similaresSimilares en SciELO
  • En proceso de indezaciónSimilares en Google

Compartir


Universidad y Salud

versión impresa ISSN 0124-7107versión On-line ISSN 2389-7066

Resumen

PINEROS-GARZON, Flor Stella  y  RODRIGUEZ-HERNANDEZ, Jorge Martín. Risk factors associated with glycemic control and metabolic syndrome in patients with type 2 diabetes mellitus. Villavicencio, Colombia. Univ. Salud [online]. 2019, vol.21, n.1, pp.61-71. ISSN 0124-7107.  https://doi.org/10.22267/rus.192101.140.

Introduction:

Type 2 diabetes mellitus (T2DM) is a chronic disease whose high prevalence makes it an important public, social and economic health problem in countries.

Objective:

To identify risk factors potentially associated with glycemic control and metabolic syndrome (MS) of patients with T2DM of a Health Services Institution (IPS) in Villavicencio, Colombia.

Materials and methods:

A transverse analytical study from secondary information was made. Multivariate models based on binomial regressions were established to analyze reasons of prevalence adjusted in two variables: metabolic syndrome and glycemic control.

Results:

More than 90% of individuals were over 49 years old; 50.6% were men; 46.6% showed the glycosylated hemoglobin test (HbA1c) figures greater than 7%; 64.5% had MS. Individuals with hyperglycemia had 3.1 times the risk of inadequate glycemic control (95% CI: 2,28-4,25, p<0.05); Those with hypothyroidism presented 1.2 times more risk of developing MS (95% CI: 1,01-1,35; p < 0.05) and those with heart disease had 1.3 times the risk of developing MS.

Conclusions:

Despite being a controlled population and in the process of monitoring, high percentage of patients presented inadequate metabolic control which increases cardiovascular risk. This suggests optimizing institutional follow-up processes.

Palabras clave : Diabetes mellitus, type 2; metabolic syndrome; glycated hemoglobin A.

        · resumen en Español     · texto en Español     · Español ( pdf )